SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 4366.
  • 2
    Blot WJ,Devesa SS,Kneller RW,Fraumeni JFJr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991; 265: 12871289.
  • 3
    Pohl H,Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005; 97: 142146.
  • 4
    van Lanschot JJ,Hulscher JB,Buskens CJ,Tilanus HW,ten Kate FJ,Obertop H. Hospital volume and hospital mortality for esophagectomy. Cancer. 2001; 91: 15741578.
  • 5
    Hulscher JB,van Sandick JW,de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002; 347: 16621669.
  • 6
    Steyerberg EW,Neville BA,Koppert LB, et al. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol. 2006; 24: 42774284.
  • 7
    May A,Gossner L,Pech O, et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol. 2002; 14: 10851091.
  • 8
    Ell C,May A,Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc. 2007; 65: 310.
  • 9
    Kakushima N,Yahagi N,Fujishiro M,Kodashima S,Nakamura M,Omata M. Efficacy and safety of endoscopic submucosal dissection for tumors of the esophagogastric junction. Endoscopy. 2006; 38: 170174.
  • 10
    Ziegler K,Sanft C,Zeitz M, et al. Evaluation of endosonography in TN staging of oesophageal cancer. Gut. 1991; 32: 1620.
  • 11
    Pech O,May A,Gunter E,Gossner L,Ell C. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. Am J Gastroenterol. 2006; 101: 22232229.
    Direct Link:
  • 12
    Lightdale CJ,Kulkarni KG. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol. 2005; 23: 44834489.
  • 13
    Scotiniotis IA,Kochman ML,Lewis JD,Furth EE,Rosato EF,Ginsberg GG. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc. 2001; 54: 689696.
  • 14
    May A,Gunter E,Roth F, et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut. 2004; 53: 634640.
  • 15
    Higuchi K,Tanabe S,Koizumi W, et al. Expansion of the indications for endoscopic mucosal resection in patients with superficial esophageal carcinoma. Endoscopy. 2007; 39: 3640.
  • 16
    Shimada H,Nabeya Y,Matsubara H, et al. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg. 2006; 191: 250254.
  • 17
    Eguchi T,Nakanishi Y,Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006; 19: 475480.
  • 18
    Tajima Y,Nakanishi Y,Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000; 88: 12851293.
  • 19
    GreeneFL, editor. AJCC Cancer Staging Atlas. New York: Springer; 2006.
  • 20
    SobinLH,FlemingID, eds. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 5th edition. Philadelphia: Lippincott-Raven; 1997.
  • 21
    Rice TW,Zuccaro GJr,Adelstein DJ,Rybicki LA,Blackstone EH,Goldblum JR. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998; 65: 787792.
  • 22
    Vieth M,Rosch T. Endoscopic mucosal resection and the risk of lymph-node metastases: indications revisited? Endoscopy. 2006; 38: 175179.
  • 23
    Buskens CJ,Westerterp M,Lagarde SM,Bergman JJ,ten Kate FJ,van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004; 60: 703710.
  • 24
    Larghi A,Lightdale CJ,Memeo L,Bhagat G,Okpara N,Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc. 2005; 62: 1623.
  • 25
    Bollschweiler E,Baldus SE,Schroder W, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy. 2006; 38: 149156.
  • 26
    Westerterp M,Koppert LB,Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005; 446: 497504.
  • 27
    Borie F,Millat B,Fingerhut A,Hay JM,Fagniez PL,De Saxce B. Lymphatic involvement in early gastric cancer: prevalence and prognosis in France. Arch Surg. 2000; 135: 12181223.
  • 28
    Liu L,Hofstetter WL,Rashid A, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005; 29: 10791085.
  • 29
    Wang KL,Wu TT,Choi IS, et al. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer. 2007; 109: 658667.
  • 30
    Izzo JG,Wu TT,Wu X, et al. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol. 2007; 25: 698707.